Skip to main content

Table 1 Patients characteristics

From: 2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease

Patient number

1

2

3

4

Age (years)

51

59

27

45

Years of ERT

1.5

6.5

7

0

Sex

M

M

M

M

Age at diagnosis (years)

50

45

20

44

Mutation

c.(336-13 T > G);

(1927G > A)

IVC-45 T > G; 536bpDel (IVS16 + 102_IVS17 + 31)

c.32-13 T > G; c.1128_1129delinsC

c-32-13 T > G; c.2214G > A

6-min walk test (m)

484

204

201

510

Wheelchair bound

No

No

No

No

Respiratory failure

Yes

Yes

Yes

No

  1. aSD standard deviation